QIAGEN Reports Full Results for Third Quarter and First Nine Months of 2019

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. CSX
7. LRCX
8. MRK
9. LVS
10. SAP

Go back to QIAGEN Reports Full Results for Third Quarter and First Nine Months of 2019

Qiagen (QGEN) Tops Q3 EPS by 1c; Offers Q4 & FY19 EPS Guidance Above Consensus

October 30, 2019 6:00 PM EDT

Qiagen (NYSE: QGEN) reported Q3 EPS of $0.36, $0.01 better than the analyst estimate of $0.35. Revenue for the quarter came in at $382.7 million versus the consensus estimate of $383.2 million.

Q3 2019 sales in line with October 7 announcement, adjusted EPS at high end of outlook:Net sales of $382.7 million (+1% actual, +3% at constant exchange rates, or CER, vs. initial outlook of ~+4-5% CER)Net loss per share of $0.71; adjusted EPS of $0.36 ($0.36 CER vs. ~$0.35-0.36 CER outlook)Decision to discontinue development of new NGS instruments and prioritize resource allocation, Q3 2019... More